TXMD icon

TherapeuticsMD
TXMD

Overview Fund Trends Analyst Outlook Journalist POV

36 hedge funds and large institutions have $9.02M invested in TherapeuticsMD in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

28% less capital invested

Capital invested by funds: $12.5M → $9.02M (-$3.47M)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$312K
Puts
$79K
Net Calls
Net Calls Change

Top Buyers

1
+$30.7K
2
+$24.5K
3
+$9.08K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.79K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.95K

Top Sellers

1
-$217K
2
-$24K
3
-$9.9K
4
UBS Group
UBS Group
Switzerland
-$5.06K
5
BlackRock
BlackRock
New York
-$1.88K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$756
27
$743
28
$422
29
$362
30
$302
31
$60
32
$48
33
$24
34
$6
35
$6
36
$3
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
1
2